Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1740 of 6351
-
New drug cocktail aims to tackle rare lymphoma
Disease control Recruiting nowThis is a multi-center, prospective cohort study. The main purpose of Cohort A is to evaluate the efficacy and safety of Orelabrutinib combined with BR (bendamustine and rituximab) for previously untreated young patients with MZL; the purpose of Cohort B is to assess the efficacy…
Phase 2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Freezing heart tissue to stop AFib: new device under study
Disease control CompletedTo collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation System (includes all BSC commercially available POLARx/POLARx Fit catheters) when used to perform pulmonary vein isolation (PVI) in the ablation treatment of de no…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug BL-B16D1 enters early human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open, multicenter, increasing dose and dose extension nonrandomized phase I clinical study to evaluate the safety, tolerance, pharmacokinetic characteristics and preliminary effectiveness of BL-B16D1 in recurrent or metastatic head and neck squamous cell carcinom…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC
-
Could a lung drug stop pancreatitis Flare-Ups?
Disease control Recruiting nowThis clinical will evaluate the safety, tolerability and early efficacy of pirenidone in patients with recurrent acute pancreatitis.
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New pill takes on KRAS-Mutant cancers in early trial
Disease control OngoingThe purpose of this study is to learn about the safety and effects of the study medicine alone or when given together with other anti-cancer therapies. This study also aims to find the best dose. This study is seeking participants who have solid tumors (a mass of abnormal cells …
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat breast cancer
Disease control Recruiting nowThis phase 1, single-center, open-label study explores the safety of escalating doses of chimeric antigen receptor T cells (CAR-T) cells in subjects with relapsed/refractory triple-negative breast cancer (TNBC).
Phase 1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could skipping radiation to the tongue reduce side effects without raising cancer risk?
Disease control Recruiting nowThis study will test whether limiting standard photon intensity modulated radiation therapy (IMRT) to exclude the oral tongue surgical site can decrease the risk of side effects caused by oral radiation. The researchers will also find out if this approach affects the rate of dise…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New balloon treatment could unclog tiny heart arteries without stents
Disease control By invitation onlyThe GENOSS PCB-De Novo study aims to evaluate the long-term efficacy and safety of a paclitaxel-coated balloon catheter containing shellac and vitamin E excipients (Genoss® DCB) in patients with De novo small coronary artery disease.
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:26 UTC
-
IPad game aims to train young brains to fight OCD
Symptom relief Recruiting nowThis study aims to examine the effects of a game-like program called cognitive control training (CT) for children with obsessive compulsive disorder (OCD). Children enrolled in this study will receive 4 weeks of the at-home computerized cognitive training program (AKL-T01) delive…
Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
5 sessions instead of 40: new prostate cancer radiation trial launches
Disease control Recruiting nowTo look at the safety and effectiveness of stereotactic body radiation therapy (SBRT) in treating advanced or high-risk prostate cancer.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can medical records reveal how fast lung function fades after transplant?
Knowledge-focused CompletedThe Primary Objective of this study was to evaluate the FEV1 trajectory of patients diagnosed with CLAD-BOS. The Secondary Objectives of this study were: * To describe demographics of patients diagnosed with CLAD-BOS * To describe clinical characteristics following lung transpl…
Sponsor: Zambon SpA • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Stitch and hormone combo may stop preterm birth
Prevention Recruiting nowThis study compares the effectiveness of cervical cerclage with vaginal progesterone to vaginal progesterone only for the prevention of preterm birth in women with a singleton pregnancy and a short cervical length. Participants will be randomly assigned in a 1:1 ratio to receive …
Sponsor: Mỹ Đức Hospital • Aim: Prevention
Last updated Jun 26, 2026 18:16 UTC
-
Universal flu vaccine enters first human trial
Vaccine CompletedThis study is a single center, randomized, double-blind, placebo-controlled, dose-finding, FIH, Phase 1 study to assess the safety, tolerability, and immunogenicity of the adjuvanted Universal Influenza Vaccine (fH1/DSP-0546LP) after IM administrations in healthy adults.
Phase 1 • Sponsor: Sumitomo Pharma Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 12:09 UTC
-
AI and poop analysis could revolutionize colon cancer screening
Diagnosis Recruiting nowColorectal cancer (CRC) is the second most common type of cancer worldwide. The European Union recommends national CRC screening for people aged between 50 and 74. Generally, an immunological test called FIT (Fecal Immunochemical Test), based on the quantitative detection of huma…
Sponsor: Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement • Aim: Diagnosis
Last updated Jun 26, 2026 17:39 UTC
-
Robotic lung biopsy: a sharper tool for spotting cancer?
Diagnosis OngoingThis randomized controlled trial evaluates the integration of cone-beam computed tomography (CBCT) and robotic-assisted bronchoscopy (RAB) for diagnosing pulmonary lesions, hypothesizing improved diagnostic yield compared to traditional methods. The trial involves 2 study arms (2…
Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Can deep cleaning reverse Smoking's toll on gum disease?
Knowledge-focused CompletedThe goal of this observational is to analyze the relationship between levels of interleukin-18 (IL-18), interleukin (IL-1β), Tumor Necrosis Factor-alpha (TNF-α), interleukin-10 (IL-10), transforming growth factor beta (TGF-β), Nucleotide-binding oligomerization domain -like recep…
Sponsor: Necmettin Erbakan University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Personalized preventive care aims to cut deaths by 20% in low-income communities
Disease control OngoingThe purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs b…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Sound waves take aim at pancreatic tumors: new trial tests HIFU
Disease control PausedThis is a phase I/II, multicenter trial for patients with locally advanced and unresectable pancreatic tumours : * A Phase I evaluating the tolerance of intraoperative High Intensity Focused Ultrasound (HIFU) intervention on the pancreatic lesion. * A non-randomized Phase II eva…
Phase 1/2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New Antibody-Drug conjugate takes aim at tough leukemias
Disease control OngoingThis is the first-in-human trial with BYON4413 to evaluate safety, PK, immunogenicity, and anti-leukemia activity of BYON4413 in patients with AML or MDS.
Phase 1 • Sponsor: Byondis B.V. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a blood filtering technique reveal more about prostate cancer spread?
Knowledge-focused Recruiting nowThe goal of this observational study is to compare the number of CTCs enriched by both sampling methods, leukapheresis and collection of peripheral blood in metastatic prostate cancer patients. The main questions it aims to answer are: 1. The advantages and disadvantages of two …
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC